ESMO 2017: CDK4/6 inhibitors from a patient’s perspective
ESMO 2017: CDK4/6 inhibitors from a patient’s perspective
Managing osteonecrosis of the jaw
Identifying rare mutations in lung cancer
iManageCancer: Data mining and analysis
iManageCancer: Mobile data collection to track patient wellbeing
The challenge of approving add-on therapies for patients with metastatic cancer
Current and future immune approaches in precision medicine
Big data, scientific wellness and transforming healthcare
Bayesian adaptive trial designs for precision medicine
Genomic predictors of treatment response in prostate cancer
Impact of mutational profile at diagnosis for MDS/CML
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refractory NHL